학술논문
waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies.
Document Type
Article
Author
Zinzani, Pier Luigi; Mayer, Jiri; Benjamini, Ohad; Berkovits, Alejandro; Glimelius, Ingrid; Stevens, Don A.; Chaudhry, Arvind; Muzaffer Demir, Ahmet; Garcia Sanz, Ramón; Seog Kim, Won; Li, Fei; Halka, Janusz; Marin-Niebla, Ana; Ozcan, Muhit; Paszkiewicz-Kozik, Ewa; Santoro, Armando; Ren, Yixin; Ogbu, Uzor; Marinello, Patricia; Jurczak, Wojciech
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS7595-TPS7595, 1p
Subject
Language
ISSN
0732183X